Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 06, 2018

SELL
$284.6 - $344.99 $1.99 Million - $2.41 Million
-6,999 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $13,264 - $16,538
42 Added 0.6%
6,999 $2.41 Million
Q4 2017

Feb 14, 2018

SELL
$358.63 - $469.95 $9.13 Million - $12 Million
-25,445 Reduced 78.53%
6,957 $2.62 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $14 Million - $16.3 Million
32,402
32,402 $14.5 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Quest Investment Management LLC Portfolio

Follow Quest Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Investment Management LLC with notifications on news.